|
Volumn 35, Issue 7, 1997, Pages 765-770
|
Antiamoebic activity of 3,3′- fluro-4,4′-di-(pyrrolidine-2-ylidene amino)-diphenyl (liroldine), against experimentally infected intestinal and hepatic amoebiasis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIAMEBIC AGENT;
CHLOROQUINE;
HL 707;
LIROLDINE;
METRONIDAZOLE;
NITROIMIDAZOLE DERIVATIVE;
ORNIDAZOLE;
PAROMOMYCIN;
UNCLASSIFIED DRUG;
AMEBIASIS;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CONTROLLED STUDY;
DRUG EFFICACY;
ENTAMOEBA HISTOLYTICA;
IN VITRO STUDY;
IN VIVO STUDY;
LD 50;
LIVER AMEBIASIS;
NONHUMAN;
AMEBIASIS;
AMEBICIDES;
ANIMALS;
BIPHENYL COMPOUNDS;
CRICETINAE;
HUMANS;
INTESTINAL DISEASES, PARASITIC;
LIVER DISEASES, PARASITIC;
MESOCRICETUS;
MICE;
MICROBIAL SENSITIVITY TESTS;
PYRROLIDINES;
RATS;
RATS, WISTAR;
ANIMALIA;
CRICETINAE;
ENTAMOEBA HISTOLYTICA;
MESOCRICETUS AURATUS;
RATTUS NORVEGICUS;
|
EID: 0030724569
PISSN: 00195189
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (13)
|